AI-generated summary
The authors studied 19 patients with late luteal phase dysphoric disorder and 11 healthy comparison subjects in a crossover trial of bright white morning light, bright white evening light, and dim red placebo light. All light treatments were reported to significantly reduce depressive ratings from baseline. The abstract does not report wavelengths for the red placebo light or details of the comparison between treatments.
- Who or what was studied
- 19 patients with late luteal phase dysphoric disorder and 11 healthy comparison subjects
- Limits stated in the abstract
- The abstract does not report a comparison between active and placebo light, and it does not state the study's sample-size justification or outcome certainty.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatryonline.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.